Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06367816
Other study ID # 13509
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 11, 2024
Est. completion date December 31, 2024

Study information

Verified date April 2024
Source University of Genova
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Thus far, the closed-loop ventilation mode INTELLiVENT-ASV has been extensively tested in various groups of critically ill patients, and has been shown to be effective and safe in various groups of ventilated patients, including those at risk of acute respiratory distress syndrome (ARDS), patients with ARDS, and patients with chronic obstructive pulmonary disease (COPD). Some of these studies included acute brain injury (ABI) patients, but the effectiveness, efficacy and safety of INTELLiVENT-ASV has never been thoroughly tested in these patients. The current study will investigate the effectiveness in providing both brain- and lung protective ventilation, the safety and the efficacy of a closed-loop ventilation mode (INTELLiVENT-ASV) in acute brain injury patients, using breath-by-breath data.


Description:

Rationale: Closed-loop ventilation has been proven effective in lung-protective ventilation but its effectiveness, safety and efficacy in providing both lung- and brain-protective ventilation in patients with acute brain injury has not been investigated. Objective: To evaluate the effectiveness, efficacy and safety of INTELLiVENT-ASV with respect to brain- and lung-protective ventilation in ABI patients Hypothesis: We hypothesize that INTELLiVENT-ASV is effective with regard to brain- and lung-protective ventilation (that is achieving brain- and lung- protective targets), efficacious (that is improving outcomes), and that INTELLiVENT-ASV is safe in invasively ventilated ABI patients. Study design: Single-center, crossover trial. Methods: In this prospective observational study, breath-by-breath ventilation data will be available from before and after the switch to closed-loop ventilation with INTELLiVENT-ASV, wherein the decision to switch is determined by the attending healthcare worker, i.e., not protocolized and only for clinical/organizational reasons. High granular data are collected both before and after this switch, limited to three hours for conventional and three hours for closed-loop ventilation. Neuromonitoring is part of current clinical practice and data will be collected only when available. Study population: Invasively ventilated patients diagnosed with acute brain injury Methods: When the ventilator is switched upon the caregivers decision, data will be collected from three hours before the switch and three hours after the switch. Study endpoints: The primary composite endpoint is the proportion of breaths and proportion of time within predefined zones of ventilation (based on VT and airway pressures, saturation of peripheral O2 (SpO2) and end-tidal CO2 (EtCO2).


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 105 Years
Eligibility Inclusion Criteria: - aged = 18 years; - intubated and receiving invasive ventilation for ABI; - admitted to the Intensive Care Unit Exclusion Criteria: - receiving ventilation with a ventilator that does not allow INTELLiVENT-ASV

Study Design


Intervention

Procedure:
INTELLiVENT
Closed-loop mode of ventilation
Conventional ventilation
Mode of ventilation

Locations

Country Name City State
Italy UO Clinica Anestesiologica e Terapia Intensiva, IRCCS Ospedale Policlinico San Martino Genova GE

Sponsors (1)

Lead Sponsor Collaborator
University of Genova

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proportion of breaths in predefined zones of ventilation 7 hours from baseline
Primary Proportion of time in predefined zones of ventilation 7 hours from baseline
Secondary Intracerebral changes assessed by multimodal neuromonitoring available 7 hours from baseline
Secondary Changes on Electrical Impedence Tomography when available 7 hours from baseline
Secondary Effectiveness in primary ABI patients vs non primary ABI patients 7 hours from baseline
Secondary Episodes and time of high maximum airway pressure 7 hours from baseline
Secondary Episodes and time of high respiratory rate 7 hours from baseline
Secondary Incidence of severe hypoxemia 7 hours from baseline
Secondary Incidence of severe hypercapnia 7 hours from baseline
Secondary Discontinuation of ventilatory mode (yes or no) 7 hours from baseline
Secondary Percentage of breaths in the predefined 'critical' ventilation zone 7 hours from baseline
Secondary Incidence of pneumothorax 8 hours from baseline
Secondary Efficacy on glascow coma scale 7 hours from baseline
Secondary Duration of ventilation in survivors 90 days
Secondary Ventilator free days 90 days
Secondary Intensive care unit length of stay 90 days
Secondary Hospital length of stay 90 days
Secondary 28-day mortality 90 days
Secondary 90-day mortality 90 days
Secondary Number of alarms 7 hours from baseline
Secondary Number of manual adjustments 7 hours from baseline
See also
  Status Clinical Trial Phase
Completed NCT04107467 - Mechanical Ventilation Epidemiology in Argentina.
Recruiting NCT03181620 - Sedation Administration Timing: Intermittent Dosing Reduces Time to Extubation N/A
Recruiting NCT03941002 - Continuous Evaluation of Diaphragm Function N/A
Recruiting NCT03697785 - Weaning Algorithm for Mechanical VEntilation N/A
Recruiting NCT05459116 - Visualization of Inspiratory Effort and Respiratory Mechanics to Promote Lung- and Diaphragm Protective Ventilation N/A
Completed NCT01170156 - Fluid Leakage Past Tracheal Tube Cuff : Effect of Suctioning Manoeuvre N/A
Recruiting NCT05141396 - Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH) N/A
Completed NCT04512677 - Ventilatory Weaning Guided by a New Index N/A
Withdrawn NCT00536445 - Use of NAVA in Intubated Preterm Phase 1/Phase 2
Completed NCT00097630 - ABC Trial: Awakening and Breathing Controlled N/A
Recruiting NCT04602182 - Effectiveness of Musicotherapy in Weaning From Mechanical Ventilation N/A
Recruiting NCT06120660 - Musical Intervention on Stress Effects in Critically Ill Patients N/A
Active, not recruiting NCT04023643 - Pediatric Ventilation Weaning N/A
Recruiting NCT03684291 - Hemodynamic Effects of Ventilation Modes
Recruiting NCT06195475 - Association Between Tidal Volume and Mortality in Pressure Support in Adults Under Invasive Mechanical Ventilation
Completed NCT05254691 - WOB and Paediatric Mechanical Ventilation N/A
Terminated NCT00790725 - Proportional Assist Ventilation vs Pressure Support Ventilation N/A
Completed NCT00638339 - Effects Of Invasive And Noninvasive Mechanical Ventilation On Sleep In The Intensive Care Unit (ICU)
Not yet recruiting NCT03255356 - Ventilation in Cardiac Surgery N/A
Completed NCT01155648 - Pressure Support During Chest Wall Compression N/A